March 6th, 2025: Federal Judge Blocks Pharmacies from Making Copies of Weight Loss Drugs A federal judge has ruled against compounding pharmacies producing their own versions of Eli Lillys diabetes and weight loss drugs, Zepbound and Mounjaro
Tlc-399 21
A common thread among new treatments is the activation of energy- sensing pathways, especially AMP- activated protein kinase (AMPK), which helps the liver break down fatty acids, stops lipogenesis and reduces inflammation and fibrosis
Fer-1 derivatives such as SRS1192 exhibit greater metabolic stability and effectiveness compared to Fer-1 (247, 248)
[8] With that framing set, the sections below compare the two on structure, mechanism, regulatory status, human evidence, safety, and the single most important caveat of all: no published trial has ever compared them head-to-head
Personalized Alternatives: PlexusDx Precision-Based Options Rather than combine medications with limited evidence, PlexusDx offers compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan as a single-agent foundation for weight loss
